These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 16705124)

  • 1. Statin use and breast cancer: prospective results from the Women's Health Initiative.
    Cauley JA; McTiernan A; Rodabough RJ; LaCroix A; Bauer DC; Margolis KL; Paskett ED; Vitolins MZ; Furberg CD; Chlebowski RT;
    J Natl Cancer Inst; 2006 May; 98(10):700-7. PubMed ID: 16705124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-lowering drug use and breast cancer in older women: a prospective study.
    Cauley JA; Zmuda JM; Lui LY; Hillier TA; Ness RB; Stone KL; Cummings SR; Bauer DC
    J Womens Health (Larchmt); 2003 Oct; 12(8):749-56. PubMed ID: 14588125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin drugs and risk of advanced prostate cancer.
    Platz EA; Leitzmann MF; Visvanathan K; Rimm EB; Stampfer MJ; Willett WC; Giovannucci E
    J Natl Cancer Inst; 2006 Dec; 98(24):1819-25. PubMed ID: 17179483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between statins and cancer incidence in a veterans population.
    Farwell WR; Scranton RE; Lawler EV; Lew RA; Brophy MT; Fiore LD; Gaziano JM
    J Natl Cancer Inst; 2008 Jan; 100(2):134-9. PubMed ID: 18182618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins and cancer risk.
    Karp I; Behlouli H; Lelorier J; Pilote L
    Am J Med; 2008 Apr; 121(4):302-9. PubMed ID: 18374689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users.
    Kumar AS; Benz CC; Shim V; Minami CA; Moore DH; Esserman LJ
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1028-33. PubMed ID: 18463402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lipids, lipid-lowering drugs, and the risk of breast cancer.
    Eliassen AH; Colditz GA; Rosner B; Willett WC; Hankinson SE
    Arch Intern Med; 2005 Oct; 165(19):2264-71. PubMed ID: 16246993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol-lowering drugs and colorectal cancer incidence in a large United States cohort.
    Jacobs EJ; Rodriguez C; Brady KA; Connell CJ; Thun MJ; Calle EE
    J Natl Cancer Inst; 2006 Jan; 98(1):69-72. PubMed ID: 16391373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene.
    Martino S; Cauley JA; Barrett-Connor E; Powles TJ; Mershon J; Disch D; Secrest RJ; Cummings SR;
    J Natl Cancer Inst; 2004 Dec; 96(23):1751-61. PubMed ID: 15572757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary fat and postmenopausal invasive breast cancer in the National Institutes of Health-AARP Diet and Health Study cohort.
    Thiébaut AC; Kipnis V; Chang SC; Subar AF; Thompson FE; Rosenberg PS; Hollenbeck AR; Leitzmann M; Schatzkin A
    J Natl Cancer Inst; 2007 Mar; 99(6):451-62. PubMed ID: 17374835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
    Anderson GL; Chlebowski RT; Rossouw JE; Rodabough RJ; McTiernan A; Margolis KL; Aggerwal A; David Curb J; Hendrix SL; Allan Hubbell F; Khandekar J; Lane DS; Lasser N; Lopez AM; Potter J; Ritenbaugh C
    Maturitas; 2006 Sep; 55(2):103-15. PubMed ID: 16815651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study.
    Chen Z; Maricic M; Bassford TL; Pettinger M; Ritenbaugh C; Lopez AM; Barad DH; Gass M; Leboff MS
    Arch Intern Med; 2005 Mar; 165(5):552-8. PubMed ID: 15767532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin use and risk of colorectal cancer.
    Coogan PF; Smith J; Rosenberg L
    J Natl Cancer Inst; 2007 Jan; 99(1):32-40. PubMed ID: 17202111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study.
    Rejnmark L; Vestergaard P; Mosekilde L
    Calcif Tissue Int; 2006 Jul; 79(1):27-36. PubMed ID: 16868664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study.
    Boudreau DM; Gardner JS; Malone KE; Heckbert SR; Blough DK; Daling JR
    Cancer; 2004 Jun; 100(11):2308-16. PubMed ID: 15160333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative.
    Harris RE; Chlebowski RT; Jackson RD; Frid DJ; Ascenseo JL; Anderson G; Loar A; Rodabough RJ; White E; McTiernan A;
    Cancer Res; 2003 Sep; 63(18):6096-101. PubMed ID: 14522941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins and the risk of lung, breast, and colorectal cancer in the elderly.
    Setoguchi S; Glynn RJ; Avorn J; Mogun H; Schneeweiss S
    Circulation; 2007 Jan; 115(1):27-33. PubMed ID: 17179016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality.
    Bardia A; Ebbert JO; Vierkant RA; Limburg PJ; Anderson K; Wang AH; Olson JE; Vachon CM; Cerhan JR
    J Natl Cancer Inst; 2007 Jun; 99(11):881-9. PubMed ID: 17551148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.